Carly Krystopik
About Carly Krystopik
Carly Krystopik is a Research Scientist I at Bristol-Myers Squibb with over ten years of experience in microbiology, specializing in GMP testing and documentation review.
Company
Carly Krystopik is currently employed at Bristol-Myers Squibb in New Brunswick, New Jersey, where she holds the position of Research Scientist I. Bristol-Myers Squibb is a global biopharmaceutical company known for its dedication to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases.
Title
Carly Krystopik serves as a Research Scientist I at Bristol-Myers Squibb. Her role involves ensuring that current practices comply with industry guidelines and regulatory expectations. She is proficient in the creation, review, and revision of procedures, protocols, reports, and forms, essential for maintaining high standards of scientific research and development.
Education and Expertise
Carly Krystopik studied at the University of Rhode Island, where she earned a Bachelor of Science (B.S.) in Microbiology, General, from 2004 to 2008. She completed her high school education at South Plainfield High School, from 2000 to 2004. She has over ten years of experience as a microbiologist, specializing in GMP testing and documentation. Her expertise includes the review of Bacterial Endotoxin tests, TOC, Conductivity, HPC, Microbial Identification, Bioburden, MLT, Growth Promotion, Antibiotic testing, and AET.
Background
Carly Krystopik began her career at Celsis as a Data Reviewer, where she worked from 2008 to 2011 in Edison, New Jersey. She then joined Bristol-Myers Squibb, starting as a Contract Scientist - Data Reviewer from 2011 to 2013. She subsequently served as Associate Research Scientist I from 2013 to 2016 and then as Associate Research Scientist II from 2016 to 2018. Her current role at Bristol-Myers Squibb is that of a Research Scientist I.
Achievements
Carly Krystopik is noted for performing in-process bioburden testing of parenteral products and in-use hold time studies of final products to define commercial labeling requirements. She is skilled in reviewing autoclave qualifications, biological indicator verification and release, and numerous equipment calibrations. Her thorough approach in the review and documentation of various microbiological tests and procedures ensures excellence in scientific research at Bristol-Myers Squibb.